Clinical Trial Survey

September 29, 2020
We are pushing forward in our mission to find targeted treatments for Dup15q Syndrome through research and clinical trials.  The purpose of this Clinical Trial Survey is to   answer the questions of our community in regards to Clinical Trials and fill gaps in clinical trial readiness information provided to the community. 
This survey is anonymous with the option to add your contact information for follow up on potential clinical trials.
 

Start Survey

Related Posts

Register for the LADDER Database

Register for the LADDER Database

The Dup15q Alliance is excited to announce the launch of a new program designed to help advance research and clinical service for individuals living with Dup15q syndrome! Linking Angelman and Dup15q Databases for Expanded Research (LADDER) will allow information...

EEG Database

EEG Database

In order to support research of brain development and activity in as many dup15q syndrome patients as possible the Dup15q Alliance has created an electroencephalogram (EEG) and  magnetic resonance imaging (MRI) storage system that families can directly upload...

ARCADE and ENDYMION Studies

ARCADE and ENDYMION Studies

ARCADE Study   ARCADE is a Phase 2 open-label, signal-finding pilot study designed to inform the potential for future development of soticlestat in CDD and Dup15q. The study enrolled 20 patients, ages 2 to 55 years, with refractory epileptic seizures associated with...